Search Results - "Yamasaki, Kenshi"

Refine Results
  1. 1

    Psoriasis and Antimicrobial Peptides by Takahashi, Toshiya, Yamasaki, Kenshi

    “…Psoriasis is a systemic inflammatory disease caused by crosstalk between various cells such as T cells, neutrophils, dendritic cells, and keratinocytes…”
    Get full text
    Journal Article
  2. 2

    Melanogenesis Connection with Innate Immunity and Toll-Like Receptors by Koike, Saaya, Yamasaki, Kenshi

    “…The epidermis is located in the outermost layer of the living body and is the place where external stimuli such as ultraviolet rays and microorganisms first…”
    Get full text
    Journal Article
  3. 3

    Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan by Yamasaki, Kenshi, Miyachi, Yoshiki

    Published in Journal of dermatology (01-12-2022)
    “…There is a lack of contemporary data on rosacea originating in Japan. Using baseline data from a randomized, phase 3 study of 130 Japanese patients with…”
    Get full text
    Journal Article
  4. 4

    The molecular pathology of rosacea by Yamasaki, Kenshi, Gallo, Richard L

    Published in Journal of dermatological science (01-08-2009)
    “…Abstract Rosacea is a common and chronic inflammatory skin disease that affects over 10 million Americans. Although the phenotypes of rosacea are clinically…”
    Get full text
    Journal Article
  5. 5

    Rosacea as a disease of cathelicidins and skin innate immunity by Yamasaki, Kenshi, Gallo, Richard L

    “…Rosacea is a common and chronic inflammatory skin disease most frequently seen in groups of genetically related individuals. Although the symptoms of rosacea…”
    Get more information
    Journal Article
  6. 6

    Facial UV photo imaging for skin pigmentation assessment using conditional generative adversarial networks by Kojima, Kaname, Shido, Kosuke, Tamiya, Gen, Yamasaki, Kenshi, Kinoshita, Kengo, Aiba, Setsuya

    Published in Scientific reports (13-01-2021)
    “…Skin pigmentation is associated with skin damages and skin cancers, and ultraviolet (UV) photography is used as a minimally invasive mean for the assessment of…”
    Get full text
    Journal Article
  7. 7

    Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study by Miyachi, Yoshiki, Yamasaki, Kenshi, Fujita, Tomomitsu, Fujii, Chie

    Published in Journal of dermatology (01-03-2022)
    “…Topical metronidazole is not currently approved in Japan as a treatment for the indication of rosacea, although 0.75% metronidazole gel was authorized in 2014…”
    Get full text
    Journal Article
  8. 8

    The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors by Amagai, Ryo, Takahashi, Toshiya, Terui, Hitoshi, Fujimura, Taku, Yamasaki, Kenshi, Aiba, Setsuya, Asano, Yoshihide

    “…An active form of cathelicidin antimicrobial peptide, LL-37, has immunomodulatory and stimulatory effects, though the specific pathways are not clear. The…”
    Get full text
    Journal Article
  9. 9

    TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by Keratinocytes by Yamasaki, Kenshi, Kanada, Kimberly, Macleod, Daniel T., Borkowski, Andrew W., Morizane, Shin, Nakatsuji, Teruaki, Cogen, Anna L., Gallo, Richard L.

    Published in Journal of investigative dermatology (01-03-2011)
    “…A diverse environment challenges skin to maintain temperature, hydration, and electrolyte balance while also maintaining normal immunological function. Rosacea…”
    Get full text
    Journal Article
  10. 10

    Ustekinumab treatment for hidradenitis suppurativa by Takeda, Kana, Kikuchi, Katsuko, Kanazawa, Yoshitake, Yamasaki, Kenshi, Aiba, Setsuya

    Published in Journal of dermatology (01-12-2019)
    “…Hidradenitis suppurativa (HS) is a follicular occlusive inflammatory skin disease that occurs in the axilla, groin, buttocks and vulval region. Control of the…”
    Get full text
    Journal Article
  11. 11

    Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea by Coda, Alvin, Murakami, Masamoto, Descargues, Pascal, Dorschner, Robert A, Hovnanian, Alain, Gallo, Richard L, Ohtake, Takaaki, Di Nardo, Anna, Bonnart, Chrystelle, Yamasaki, Kenshi, Bardan, Antonella, Morhenn, Vera B

    Published in Nature medicine (01-08-2007)
    “…Acne rosacea is an inflammatory skin disease that affects 3% of the US population over 30 years of age and is characterized by erythema, papulopustules and…”
    Get full text
    Journal Article
  12. 12

    Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts by Kumtornrut, Chanat, Yamauchi, Takeshi, Koike, Saaya, Aiba, Setsuya, Yamasaki, Kenshi

    Published in Journal of dermatological science (01-03-2019)
    “…•Androgens enhance AREG, EREG, FGF10, and IGFBP5 production from fibroblasts through androgen receptors.•AREG, EREG, FGF10, and IGFBP5 are more abundant in…”
    Get full text
    Journal Article
  13. 13

    Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty‐six‐week phase 3 open‐label study by Yamasaki, Kenshi, Yamanaka, Keiichi, Zhao, Yiwei, Iwano, Shunsuke, Takei, Keiko, Suzuki, Koji, Yamamoto, Toshiyuki

    Published in Journal of dermatology (01-12-2020)
    “…This phase 3 multicenter study, including 26‐week treatment and extension periods, evaluated the efficacy and safety of adalimumab in Japanese patients with…”
    Get full text
    Journal Article
  14. 14

    Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52‐week phase 3 open‐label study by Yamasaki, Kenshi, Yamanaka, Keiichi, Zhao, Yiwei, Iwano, Shunsuke, Takei, Keiko, Suzuki, Koji, Yamamoto, Toshiyuki

    Published in Journal of dermatology (01-05-2022)
    “…In this 52‐week, phase 3 open‐label study, efficacy and safety of adalimumab were evaluated in Japanese patients with active ulcers due to pyoderma gangrenosum…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Administration of oral vitamin D induces cathelicidin production in atopic individuals by Hata, Tissa R., MD, Kotol, Paul, BS, Jackson, Michelle, MD, Nguyen, Meggie, BS, Paik, Aimee, MD, Udall, Don, MD, Kanada, Kimi, BS, Yamasaki, Kenshi, MD, PhD, Alexandrescu, Doru, MD, Gallo, Richard L., MD, PhD

    Published in Journal of allergy and clinical immunology (01-10-2008)
    “…To the Editor: Atopic dermatitis (AD) is a chronic skin condition that affects 10% to 20% of children and 1% to 3% of adults.1 Individuals with atopic…”
    Get full text
    Journal Article
  17. 17

    Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands by Morizane, Shin, Yamasaki, Kenshi, Mühleisen, Beda, Kotol, Paul F., Murakami, Masamoto, Aoyama, Yumi, Iwatsuki, Keiji, Hata, Tissa, Gallo, Richard L.

    Published in Journal of investigative dermatology (01-01-2012)
    “…Here we show that keratinocytes in psoriatic lesional skin express increased Toll-like receptor (TLR) 9 that similarly localizes with elevated expression of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Red light-promoted skin barrier recovery: Spatiotemporal evaluation by transepidermal potential by Abe, Yuina, Konno, Hajime, Yoshida, Shotaro, Yamauchi, Takeshi, Yamasaki, Kenshi, Denda, Mitsuhiro, Nishizawa, Matsuhiko

    Published in PloS one (10-07-2019)
    “…The light-promoted recovery of epidermal barrier of skin was evaluated by the associated recovery of transepidermal potential (TEP), the potential difference…”
    Get full text
    Journal Article